BIOLASE (NASDAQ:BIOL) vs. SmileDirectClub (NASDAQ:SDC) Critical Analysis

BIOLASE (NASDAQ:BIOL) and SmileDirectClub (NASDAQ:SDC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Insider and Institutional Ownership

37.7% of BIOLASE shares are owned by institutional investors. 4.5% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.


This table compares BIOLASE and SmileDirectClub’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BIOLASE -47.46% -159.26% -43.77%
SmileDirectClub N/A N/A N/A

Analyst Ratings

This is a summary of recent ratings and recommmendations for BIOLASE and SmileDirectClub, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIOLASE 0 1 3 0 2.75
SmileDirectClub 0 0 10 0 3.00

BIOLASE currently has a consensus target price of $2.50, suggesting a potential upside of 257.14%. SmileDirectClub has a consensus target price of $21.78, suggesting a potential upside of 129.24%. Given BIOLASE’s higher probable upside, equities research analysts clearly believe BIOLASE is more favorable than SmileDirectClub.

Valuation and Earnings

This table compares BIOLASE and SmileDirectClub’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BIOLASE $46.15 million 0.33 -$21.52 million ($0.85) -0.82
SmileDirectClub N/A N/A N/A N/A N/A

SmileDirectClub has lower revenue, but higher earnings than BIOLASE.


SmileDirectClub beats BIOLASE on 5 of the 9 factors compared between the two stocks.

BIOLASE Company Profile

BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the worldwide. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company also markets, sells, and distributes dental imaging equipment comprising three-dimensional (3D) CAD/CAM intra-oral scanners and digital dentistry software. Its dental imaging products include 3Shape TRIOS intraoral scanners, digital impression systems, and software for taking 3D scans, which are used to design crowns, study models, surgical guides for implant placement, and event orthodontic and athletic appliances. In addition, the company manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. It sells its products primarily to dentists in general practice through its field sales force and distributor network. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.

SmileDirectClub Company Profile

SmileDirectClub, Inc. operates a teledentistry platform that provides member's with a customized clear aligner therapy treatment in the United States and internationally. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment proprietary with a network of approximately 240 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck. It offers aligners, impression kits, whitening gels, and retainers. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit